About Cradle
Cradle is a protein engineering software platform that leverages artificial intelligence to accelerate the design and optimization of therapeutic and industrial proteins. The company serves leading biopharma and industrial biotechnology R&D teams, including Novo Nordisk, argenx, AbbVie, Johnson & Johnson, Novonesis, and Corteva. Cradle's platform enables scientists to generate protein candidates that meet multiple objectives simultaneously—including binding affinity, stability, expression, specificity, and activity—while learning from each round of experimental data. The technology works across diverse protein modalities including antibodies, enzymes, vaccines, and peptides, supporting programs from hit identification through lead optimization. Teams using Cradle report 2-12x faster development timelines compared to traditional protein engineering approaches. The platform integrates with existing experimental workflows, accepting data from NGS screening, FACS, chromatography, and various assay formats. Cradle's approach combines privacy-first AI with enterprise-grade security, ensuring customer data remains proprietary and is only used to train organization-specific models. The company operates its own wet lab in Amsterdam to continuously improve model performance and validate its AI algorithms with real-world experimental data. Founded to transform protein engineering from incremental progress to compounding results, Cradle enables scientists to explore multiple design strategies simultaneously, reducing the risk of project failure while strengthening IP portfolios. The platform is designed for teams developing therapeutics, agricultural solutions, food ingredients, and industrial biocatalysts.
Clinical Focus
Medical conditions and clinical areas addressed by Cradle.
Who It Serves
Milestones & Awards
Recent Milestones
Lundbeck partnership announced for discovering and optimizing brain disorder treatments; Novonesis partnership to embed AI into biosolutions innovation; participation in Adaptyv antibody competition
Awards & Recognition
Participation in Adaptyv competition for antibody design
Key Partnerships
Company Details
- Headquarters
- Amsterdam, Netherlands
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 64 →
A2A Pharmaceuticals
AI-driven pharmaceutical company focused on discovering and developing novel drug candidates using computational biology and machine learning.
AbCellera
AbCellera uses AI and machine learning to discover and develop antibody-based therapeutics and vaccines.
Absci
Absci uses AI-powered computational biology and machine learning to accelerate drug discovery and optimize therapeutic proteins and antibodies.
Adaptyv Bio
11-50 employees
Adaptyv Bio operates the world's fastest protein validation lab, providing automated experimental testing services for AI-designed proteins. The company enables protein engineers to validate binding, expression, and thermostability of novel protein designs through a fully automated platform with 3-week turnaround times.
Aitia
Aitia is a drug discovery and development company leveraging AI and computational biology to identify novel therapeutic targets and accelerate drug development.
Anagenex
Anagenex is a biotechnology company focused on drug discovery and development. The company appears to operate in the pharmaceutical research space, though specific details about their technology platform, therapeutic areas, and target markets are not available from the provided content.
Aqemia
Aqemia is a drug discovery company advancing next-generation medicines using generative AI and deep physics. The company combines AI-augmented discovery with computational chemistry to develop novel therapeutics at scale.
Arctoris
51-200 employees
Arctoris is a Partnership Research Organisation (PRO) providing automated wet lab biology R&D and data generation services for biotech, techbio, and pharma companies through its Ulysses® robotic platform.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.